Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE: Sodium Alginate for Radiation-Induced Esophagitis in Breast Cancer
NCT06958445Phase 2Enrolling by invitation
- Sponsor
- Taipei City Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Sodium alginate in oral mucositis (OM), esophagitis, sponsored by Taipei City Hospital. Started Feb 2024; status: enrolling by invitation.
02
Drugs
Sodium alginate
03
Conditions
oral mucositis (OM)esophagitis
Beyond the preview
Go deeper on NCT06958445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06958445.